3SBio Inc. · Shenyang, Liaoning China (NASDAQ: SSRX)
| 3 A1, Rd. 10, Shenyang Economy & Technology Development Zone | Phone: +86-24-2581-1820 |
| Shenyang, Liaoning | |
| 110027 | |
| China | 
Map This Company |
3SBio Inc. Rankings
Company Description
3SBio wants to find a cure for a wide spread of ailments, including cancer and viral and autoimmune diseases. The biopharmaceutical company develops protein-based products for treating diseases in nephrology, oncology, infectious diseases, and other areas through its Shenyang Sunshine subsidiary. The company's flagship product, EPIAO, is used to increase the amount of red blood cells in patients with anemia. Other products include TPIAO, which treats a chemotherapy-induced deficiency in blood platelets, and Intefen and Inleusin for leukemia, hepatitis C, and kidney and skin cancers. 3SBio sells its products primarily through distributors in China to physicians, hospitals, clinics, and dialysis centers.
3SBio Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: SSRX |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 718 |
Executives
9 executives listed for 3SBio Inc.'s Shenyang, Liaoning location.
| Chairman | Dan Lou | |
|---|---|---|
| CEO and Director | Jing Lou | |
| EVP and COO | David Chen |